(2026). Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer. Discover Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Integrative Multi-omics Identifies a Glycosylation-based Prognostic Framework and Nominates ALG3 for Targeted Therapy in Bladder Cancer."
Discover Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Integrative Multi-omics Identifies a Glycosylation-based Prognostic Framework and Nominates ALG3 for Targeted Therapy in Bladder Cancer."
Discover Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.